Currently Viewing:
AcademyHealth 2018 National Health Policy Conference
Health Reform X.0 Panel Debates Medicaid, Other Topics at Health Policy Conference
February 05, 2018
Policy Talk Tries Shifting Conversation About Who Pays for What in Healthcare
February 06, 2018
As Budget Deadline Looms, Former Congressional Aides Talk Health Policy at Conference
February 06, 2018
Surgeon General to Policy Conference: Let's Link Health to Economy, Defense
February 06, 2018
Currently Reading
Dr Robert Dubois Discusses Addressing Healthcare Spending
February 14, 2018
Gail Wilensky Discusses the Impact of Waivers on State Medicaid Programs
February 19, 2018
Anne L. Schwartz Explains Data on Newly-Eligible Medicaid Enrollees
February 23, 2018
Dr Robert Dubois Discusses Tradeoffs When Allocating Healthcare Resources
February 26, 2018
Dr Robert Dubois Explains Challenges in Addressing Low-Value Services
March 09, 2018
Sara Rosenbaum Outlines Concerns Over Waivers in Medicaid Programs
March 13, 2018
Dr Anne L. Schwartz on Data in Healthcare Policy
March 15, 2018
Dr Robert Dubois on How NPC's Going Below the Surface Initiative Will Address How Well We Spend on Healthcare
March 20, 2018
Dr Anne L. Schwartz on Medicaid's Role in Addressing the Opioid Epidemic and Social Determinants of Health
March 25, 2018
Sara Rosenbaum Discusses Children's Healthcare
April 01, 2018
Dr Gail Wilensky Examines the Shift to Value-Based Care
April 03, 2018
Dr David Blumenthal Discusses the Best Practices for Getting to Value-Based Care
April 10, 2018
Sara Rosenbaum Discusses the Current Political Climate and the Effect on Medicaid
April 21, 2018
Dr David Blumenthal Outlines the Result of Mergers and Acquisitions in Healthcare
April 24, 2018
Sara Rosenbaum: A Disparities Agenda in Health Policy Is Needed
April 30, 2018
Dr David Blumenthal Looks Back as The Commonwealth Fund Celebrates 100 Years
May 06, 2018

Dr Robert Dubois Discusses Addressing Healthcare Spending

The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want, said Robert Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council. 


The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want, said Robert Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council. 

Trascript (slightly modified)

What do you think are the most important questions that currently need to be addressed in the conversation about healthcare spending?

I think there’s a number of important questions that need to be addressed regarding healthcare spending, and I think there’s tier 1 questions and tier 2 questions. The tier 1 questions are really the high-level ones: How much do we want to spend on healthcare in the United States? And then, how do we allocate those dollars? So those are the high-level questions.

Then underneath it is where it gets to be difficult. It’s what I like to call the third rail questions: should we be spending more in preventive care than actual treatment? Should we be spending different amounts on end-of-life care or on the elderly versus the younger folks? Should we be spending the same amount on cancer care that we do today, or should we allocate those resources differently? That’s the second-tier questions, and those frankly are the really tough ones, but unless we address those, we really won’t come up with any solutions.

What will the consequences be for the US economy if unchecked healthcare spending is not addressed?

Too often we say the problem is drug spending or the problem is hospital consolidation raising the cost of going into the hospital. That’s looking at things individually and finger pointing. What we need to do is not just look at the costs of these services, but also the benefits. So, what’s the cost of hospital care, and what are the benefits? What are the costs of medications or devices or surgery, and what are the benefits?

Only by looking at those side by side can we decide, “You know, I think we’d be better off reallocating some of our resources, which are currently being spent on things that are not high value, and shifting those dollars towards things that in fact are high value.”

We are on a journey, and the journey really is to begin to talk about these kind of things, but the destination isn’t just to talk. The destination is to get to a point where we can spend our healthcare resources more wisely so that patients get the care they need and we all get the type of innovation that we really want.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up